Skip to main content

Resmed Inc

Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

Did you know?

Earnings per share grew at a 23.0% CAGR.

Current Price

$209.43

+2.15%

GoodMoat Value

$331.31

58.2% undervalued
Profile
Valuation (TTM)
Market Cap$30.51B
P/E20.08
EV$32.71B
P/B5.11
Shares Out145.68M
P/Sales5.51
Revenue$5.54B
EV/EBITDA13.90

Resmed Inc (RMD) — Earnings Call Transcripts

42 earnings call transcripts available.

Latest Transcript

Q2 2026 Earnings Call

10 speakers6,800 words31 segments
Read →

All earnings call transcripts